Theoretical studies on beta and delta isoform-specific binding mechanisms of phosphoinositide 3-kinase inhibitors

Jingyu Zhu1, Peichen Pan, Youyong Li

  • 1Cyrus Tang Hematology Center, Soochow University, Suzhou, Jiangsu 215123, China. xinliangmao@suda.edu.cn.

Molecular Biosystems
|December 17, 2013
PubMed

Insights

Researchers explored how specific inhibitors bind to Phosphoinositide 3-kinase beta (PI3Kβ) and delta (PI3Kδ) isoforms. They found that multiple residues, not just one, determine inhibitor specificity for PI3Kβ or PI3Kδ.

Area of Science:

  • Biochemistry and Molecular Biology
  • Pharmacology and Drug Discovery

Background:

  • Phosphoinositide 3-kinase (PI3K) signaling is crucial for cell proliferation and tumorigenesis.
  • Targeting specific PI3K isoforms offers potential for selective cancer therapies with reduced toxicity.
  • PI3Kβ and PI3Kδ isoforms are less studied compared to others, highlighting a need for detailed investigation.

Purpose of the Study:

  • To investigate the binding mechanisms of isoform-specific PI3K inhibitors to PI3Kβ and PI3Kδ.
  • To identify key amino acid residues responsible for the selectivity of inhibitors towards PI3Kβ or PI3Kδ.

Main Methods:

  • Employed molecular dynamics simulations to model inhibitor-protein interactions.
  • Utilized free energy calculations to predict and quantify binding affinities.
  • Decomposed binding free energies to pinpoint contributions from individual residues.

Main Results:

  • Predicted isoform specificities of COM8, IC87114, and GDC-0941 aligned well with experimental data.
  • Identified specific residues critical for distinguishing PI3Kβ and PI3Kδ binding.
  • Confirmed that conserved ATP-binding pockets harbor distinct residues influencing selectivity.

Conclusions:

  • Inhibitor specificity for PI3Kβ versus PI3Kδ is governed by the cumulative effects of multiple residues.
  • This study provides insights into PI3K isoform-specific binding mechanisms.
  • Findings support the rational design of novel, selective PI3K inhibitors for therapeutic applications.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
7.7K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
12.1K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

3.3K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.5K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K